Arcelia Arrieta

942 total citations · 1 hit paper
21 papers, 633 citations indexed

About

Arcelia Arrieta is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Arcelia Arrieta has authored 21 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Genetics and 12 papers in Surgery. Recurrent topics in Arcelia Arrieta's work include Diabetes Management and Research (21 papers), Diabetes and associated disorders (13 papers) and Pancreatic function and diabetes (12 papers). Arcelia Arrieta is often cited by papers focused on Diabetes Management and Research (21 papers), Diabetes and associated disorders (13 papers) and Pancreatic function and diabetes (12 papers). Arcelia Arrieta collaborates with scholars based in Switzerland, Netherlands and United States. Arcelia Arrieta's co-authors include Javier Castañeda, Ohad Cohen, Tadej Battelino, John Shin, Julien Da Silva, Tim van den Heuvel, Giuseppe Lepore, Toni L. Cordero, Andrea Scaramuzza and Chantal Mathieu and has published in prestigious journals such as Diabetes Care, Diabetic Medicine and Diabetes Obesity and Metabolism.

In The Last Decade

Arcelia Arrieta

19 papers receiving 624 citations

Hit Papers

Real-World Performance of the MiniMed™ 780G System: First... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users
    2021 157 citations Julien Da Silva, Giuseppe Lepore et al. Diabetes Technology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arcelia Arrieta Switzerland 13 616 443 404 32 22 21 633
Ido Muller Israel 12 809 1.3× 675 1.5× 534 1.3× 23 0.7× 26 1.2× 13 851
Julien Da Silva Switzerland 7 442 0.7× 330 0.7× 302 0.7× 12 0.4× 16 0.7× 9 451
Toni L. Cordero United States 14 867 1.4× 656 1.5× 573 1.4× 20 0.6× 40 1.8× 27 918
Martin Cantwell United States 8 443 0.7× 379 0.9× 267 0.7× 9 0.3× 11 0.5× 8 487
Christian Wakeman United States 12 420 0.7× 274 0.6× 231 0.6× 16 0.5× 21 1.0× 16 463
Amy Steffen United States 14 767 1.2× 540 1.2× 457 1.1× 15 0.5× 16 0.7× 20 818
Liana Hsu United States 11 567 0.9× 448 1.0× 370 0.9× 11 0.3× 27 1.2× 18 612
Carla M. Frewen New Zealand 8 390 0.6× 303 0.7× 259 0.6× 9 0.3× 18 0.8× 13 419
Jonathan Burdick United States 6 372 0.6× 289 0.7× 240 0.6× 12 0.4× 14 0.6× 8 418
Renee A. Meier New Zealand 5 335 0.5× 265 0.6× 218 0.5× 8 0.3× 15 0.7× 9 356

Countries citing papers authored by Arcelia Arrieta

Since Specialization
Citations

This map shows the geographic impact of Arcelia Arrieta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arcelia Arrieta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arcelia Arrieta more than expected).

Fields of papers citing papers by Arcelia Arrieta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arcelia Arrieta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arcelia Arrieta. The network helps show where Arcelia Arrieta may publish in the future.

Co-authorship network of co-authors of Arcelia Arrieta

This figure shows the co-authorship network connecting the top 25 collaborators of Arcelia Arrieta. A scholar is included among the top collaborators of Arcelia Arrieta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arcelia Arrieta. Arcelia Arrieta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heller, Simon, David N. O’Neal, Johan Jendle, et al.. (2025). MiniMed 780G system performance in older users with type 1 diabetes: Real‐world evidence and the case for stricter glycaemic targets. Diabetes Obesity and Metabolism. 27(4). 2242–2250. 4 indexed citations
2.
Arrieta, Arcelia, Javier Castañeda, Michaël Joubert, et al.. (2025). Performance of an Automated Insulin Delivery System in People Living With Type 2 Diabetes and Insulin Resistance: First Real-World Evidence in 26 427 Users. Journal of Diabetes Science and Technology. 580927589–580927589.
3.
Chien, A., John Shin, Margaret Liu, et al.. (2025). Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States. Diabetes Technology & Therapeutics. 27(12). 989–996.
4.
Choudhary, Pratik, et al.. (2024). Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence. Diabetes Technology & Therapeutics. 26(3_suppl). 32–37. 36 indexed citations
5.
Abraham, Mary B., Arcelia Arrieta, Zheng Dai, et al.. (2024). Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience. Diabetes Technology & Therapeutics. 26(3). 190–197. 5 indexed citations
6.
Matejko, Bartłomiej, Tim van den Heuvel, Javier Castañeda, et al.. (2024). Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort. Diabetes Research and Clinical Practice. 216. 111832–111832. 3 indexed citations
7.
Castañeda, Javier, Bastiaan E. de Galan, Sander M. J. van Kuijk, et al.. (2024). The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery. Diabetes Obesity and Metabolism. 26(12). 5836–5844. 2 indexed citations
8.
Heuvel, Tim van den, Javier Castañeda, Arcelia Arrieta, et al.. (2024). Generating real‐world evidence on diabetes technology using the CareLink Personal data management system. Diabetes Obesity and Metabolism. 26(11). 4846–4853. 3 indexed citations
9.
Aktürk, Halis Kaan, Tadej Battelino, Javier Castañeda, et al.. (2024). Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes Technology & Therapeutics. 26(3_suppl). 102–106. 13 indexed citations
10.
Thrasher, James, Arcelia Arrieta, Fang Niu, et al.. (2024). Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States. Diabetes Technology & Therapeutics. 26(3_suppl). 24–31. 13 indexed citations
11.
Dekker, Pim, Tim van den Heuvel, Arcelia Arrieta, et al.. (2024). Twelve-Month Real-World Use of an Advanced Hybrid Closed-Loop System Versus Previous Therapy in a Dutch Center For Specialized Type 1 Diabetes Care. Journal of Diabetes Science and Technology. 570899475–570899475. 2 indexed citations
12.
Castañeda, Javier, Arcelia Arrieta, Tim van den Heuvel, Tadej Battelino, & Ohad Cohen. (2023). Time in Tight Glucose Range in Type 1 Diabetes: Predictive Factors and Achievable Targets in Real-World Users of the MiniMed 780G System. Diabetes Care. 47(5). 790–797. 50 indexed citations
13.
Gómez, Ana María, Luís Eduardo Calliari, Denise Reis Franco, et al.. (2023). Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system. Diabetes Obesity and Metabolism. 25(6). 1688–1697. 32 indexed citations
14.
Castañeda, Javier, Arcelia Arrieta, Tim van den Heuvel, & Ohad Cohen. (2023). The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system. Diabetes Obesity and Metabolism. 25(9). 2545–2552. 13 indexed citations
15.
Al‐Sofiani, Mohammed E., Goran Petrovski, Abdullah M. Alguwaihes, et al.. (2023). The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan. Diabetes Obesity and Metabolism. 26(3). 937–949. 18 indexed citations
16.
Arrieta, Arcelia, Tadej Battelino, Andrea Scaramuzza, et al.. (2022). Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users. Diabetes Obesity and Metabolism. 24(7). 1370–1379. 105 indexed citations
17.
Castañeda, Javier, Chantal Mathieu, Henk‐Jan Aanstoot, et al.. (2022). Predictors of time in target glucose range in real‐world users of the MiniMed 780G system. Diabetes Obesity and Metabolism. 24(11). 2212–2221. 69 indexed citations
18.
Silva, Julien Da, Giuseppe Lepore, Tadej Battelino, et al.. (2021). Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users. Diabetes Technology & Therapeutics. 24(2). 113–119. 157 indexed citations breakdown →
19.
Silva, Julien Da, Emanuele Bosi, Johan Jendle, et al.. (2021). Real‐world performance of the MiniMed™ 670G system in Europe. Diabetes Obesity and Metabolism. 23(8). 1942–1949. 43 indexed citations
20.
Choudhary, Pratik, Simona de Portu, Arcelia Arrieta, Javier Castañeda, & Fiona Campbell. (2019). Use of sensor‐integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real‐world study in the UK. Diabetic Medicine. 36(9). 1100–1108. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ido Muller Breakdown of academic impact, for papers by Julien Da Silva Breakdown of academic impact, for papers by Toni L. Cordero Breakdown of academic impact, for papers by Martin Cantwell Breakdown of academic impact, for papers by Christian Wakeman Breakdown of academic impact, for papers by Amy Steffen Breakdown of academic impact, for papers by Liana Hsu Breakdown of academic impact, for papers by Carla M. Frewen Breakdown of academic impact, for papers by Jonathan Burdick Breakdown of academic impact, for papers by Renee A. Meier
Rankless by CCL
2026